• Episode 18 - Issues with Treatments

  • Apr 22 2024
  • Duración: 1 h y 8 m
  • Podcast

Episode 18 - Issues with Treatments Por arte de portada

Episode 18 - Issues with Treatments

Escúchala gratis

Ver detalles del espectáculo

  • Resumen

  • In this episode, we’re talking about some issues with treatments. We’re looking at some drugs that have lost or might lose their approvals, or cases where additional measures are put in place for safety reasons.

    Here are some resources or references used in the research for this episode -

    Crizanlizumab statement. January 2024 » Sickle Cell Society

    Crizanlizumab - end of NHS supply » Sickle Cell Society

    FDA starts speedy review of Novartis’ sickle cell antibody - PMLiVE

    Exa-Cel (Casgevy) Gene Therapy Update » Sickle Cell Society

    Montelukast (Singulair): reminder of the risk of neuropsychiatric reactions - GOV.UK (www.gov.uk)

    Remember, you can get in touch with us via clinical.research.intro@gmail.com. Please feel free to send questions, comments and compliments for Elyse to read out on the pod. It’s fun to make Debbie squirm!

    Credit to our friend Sam Winnie for their awesome and cute music. Check out their work at https://www.samwinnie.com/
    Más Menos
activate_primeday_promo_in_buybox_DT
Enfermedades Físicas Hygiene & Healthy Living Ciencias Biológicas
Más Menos

Lo que los oyentes dicen sobre Episode 18 - Issues with Treatments

Calificaciones medias de los clientes

Reseñas - Selecciona las pestañas a continuación para cambiar el origen de las reseñas.

Reseñas de Audible.com

Opiniones de Amazon
No hay comentarios disponibles